|Videos|September 28, 2022
Dr. Linehan on her experience and learning curve with HIFU
Author(s)Urology Times staff
“I feel like [HIFU] provided patients this intermediary treatment option…It was less invasive than radiation and surgery, but still provided cancer control, or at least for some patients delayed the time until they needed a more radical treatment,” says Jennifer A. Linehan, MD.
Advertisement
In this video, Jennifer A. Linehan, MD, discusses her clinical practice and experience with high-intensity focused ultrasound (HIFU) for patients with prostate cancer. Linehan is an associate professor of urology and urologic oncology at Saint John’s Cancer Institute in Santa Monica, California.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
4
URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues
5